Key result
Editorial highlights the need to treat co-existent cardiac amyloidosis in patients with aortic stenosis.
Answers are grounded in this paper and cite their sources.
This article examines the treatment need for cardiac amyloidosis in patients with aortic stenosis, suggesting critical clinical implications.
Journal Article Aortic stenosis: need for treatment of co-existent cardiac amyloidosis? Get access Sarah A M Cuddy Sarah A M Cuddy Amyloidosis Program, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA Corresponding author. Email: [email protected] https://orcid.org/0000-0002-2124-2151 Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, ehaf558, https://doi.org/10.1093/eurheartj/ehaf558 Published: 05 September 2025
No takes yet. Share an insight, caveat, or question.
Sarah Cuddy (2025) conducted an editorial in Aortic stenosis and co-existent cardiac amyloidosis. Treatment of co-existent cardiac amyloidosis was evaluated. The abstract text is missing, providing only metadata for an article discussing the need for treatment of co-existent cardiac amyloidosis in patients with aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: